Total Funding
19
37
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
122534
Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
- Michael Kaswan: Chief Financial OfficerPast Role: Orchestra BioMed, Chief Financial Officer
- Carl Sadowsky: Chief Medical Officer
About the Company
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.
The company was founded in 2001 and headquartered
in Marlborough, Massachusetts.
